Secret to Successful Pregnancy: ERA Test
Challenges with the endometrial lining
stand as a prominent factor behind female infertility. The uterus is lined with
a vital tissue known as the endometrium, which prepares itself monthly for
potential embryo arrival. It is the very site where an embryo implants and
thrives during pregnancy. However, when this process falters, menstruation
commences, shedding the endometrial lining.
Understanding Endometrial Receptivity
In some cases, the implantation of the
embryo into the endometrium encounters obstacles. Various factors can
contribute to this, with endometrial receptivity playing a pivotal role. The
endometrium is considered receptive when it is primed for embryo implantation.
This phase of receptivity is known as the "window of implantation."
The ERA Test: A Revolutionary Approach
The ERA (Endometrial Receptivity Analysis) test marks a groundbreaking advancement in assessing endometrial receptivity, backed by published clinical effectiveness. Developed and patented by IGENOMIX R&D Department since 2009, after over a decade of intensive research, this diagnostic method enables the evaluation of a woman's endometrial receptivity status. Gynecologists can easily and swiftly conduct a biopsy in their consultation room.

Lab Sequencing Unveils the Truth
Cutting-edge laboratory, the
expression of 236 genes linked to endometrial receptivity undergoes thorough
analysis. A specially designed computational predictor processes the obtained
data, classifying the endometrium as either "Receptive" or "Non-Receptive."
In the case of receptivity, the "window of implantation" (WOI) aligns
with the biopsy day, indicating the optimal time for embryo implantation.
Conversely, non-receptivity signals a displaced WOI. Based on the initial
non-receptive result, the process may be repeated, confirming the ideal WOI.
Transferring an embryo during this optimal window greatly enhances the chances
of a successful pregnancy.
Key Advantages: Elevating Pregnancy Success Rates
ERA is a pivotal tool that has the potential to significantly boost
global pregnancy rates, achieving success rates of up to 85%* when personalized
transfers align with the test results.
Accessing ERA
For comprehensive information and to
explore the ERA test's applicability to your case, consult your Gynecologist,
who can provide further insights and guidance.
© Dr.Kanchan Durugkar. All Rights Reserved.
Designed by Quickensol